tumour suppressor cyld negatively regulates nf-kappa b signalling deubiquitination 
nf-kappab transcription factors key roles inflammation immune response oncogenesis protection apoptosis cells factors kept inactive cytoplasm association ikappab inhibitors stimulation various reagents ikappab phosphorylated ikappab kinase ikk complex degraded proteasome allowing nf-kappab translocate nucleus activate target genes report cyld tumour suppressor mutated familial cylindromatosis interacts nemo regulatory subunit ikk5 cyld also interacts directly tumour-necrosis factor receptor tnfr-associated factor traf2 adaptor molecule involved signalling members family tnf/ nerve growth factor receptors cyld deubiquitinating activity directed towards non-k48-linked polyubiquitin chains negatively modulates traf-mediated activation ikk strengthening notion ubiquitination involved ikk activation trafs suggesting cyld functions process truncations cyld found cylindromatosis result reduced enzymatic activity indicating link impaired deubiquitination cyld substrates human pathophysiology 
